{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:59:39Z","timestamp":1792040379311,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85537-7","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:26:51Z","timestamp":1736404011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Ru-Gen","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"3","key":"85537_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"85537_CR2","doi-asserted-by":"publisher","first-page":"16899","DOI":"10.1038\/s41598-023-44189-1","volume":"13","author":"S Ma","year":"2023","unstructured":"Ma, S., Chen, Q., Li, X., Fu, J. & Zhao, L. UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion. Sci. Rep. 13 (1), 16899 (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"85537_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J. Clin. 72 (5), 409\u2013436 (2022).","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"85537_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1158\/1078-0432.CCR-19-2576","volume":"26","author":"NC Dhani","year":"2020","unstructured":"Dhani, N. C. et al. Phase II trial of Cabozantinib in Recurrent\/Metastatic endometrial Cancer: a study of the Princess Margaret, Chicago, and California Consortia (NCI9322\/PHL86). Clin. Cancer Res. 26 (11), 2477\u20132486 (2020).","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"85537_CR5","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ijc.31961","volume":"145","author":"O Raglan","year":"2019","unstructured":"Raglan, O. et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int. J. Cancer. 145 (7), 1719\u20131730 (2019).","journal-title":"Int. J. Cancer"},{"issue":"6","key":"85537_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/oby.23161","volume":"29","author":"JC Brown","year":"2021","unstructured":"Brown, J. C., Carson, T. L., Thompson, H. J. & Agurs-Collins, T. The Triple Health Threat of Diabetes, obesity, and Cancer-Epidemiology, disparities, mechanisms, and interventions. Obes. (Silver Spring). 29 (6), 954\u2013959 (2021).","journal-title":"Obes. (Silver Spring)"},{"issue":"4","key":"85537_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.semnephrol.2019.04.007","volume":"39","author":"NY Spencer","year":"2019","unstructured":"Spencer, N. Y. & Stanton, R. C. The Warburg Effect, Lactate, and nearly a century of trying to Cure Cancer. Semin Nephrol. 39 (4), 380\u2013393 (2019).","journal-title":"Semin Nephrol."},{"issue":"3","key":"85537_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward, P. S. & Thompson, C. B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 21 (3), 297\u2013308 (2012).","journal-title":"Cancer Cell."},{"issue":"12","key":"85537_CR9","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1089\/ars.2017.6990","volume":"28","author":"T Ren","year":"2018","unstructured":"Ren, T. et al. MCUR1-Mediated Mitochondrial Calcium Signaling Facilitates Cell Survival of Hepatocellular Carcinoma via reactive oxygen species-dependent P53 degradation. Antioxid. Redox Signal. 28 (12), 1120\u20131136 (2018).","journal-title":"Antioxid. Redox Signal."},{"issue":"22","key":"85537_CR10","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s00018-020-03536-5","volume":"77","author":"A Kirtonia","year":"2020","unstructured":"Kirtonia, A., Sethi, G. & Garg, M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell. Mol. Life Sci. 77 (22), 4459\u20134483 (2020).","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"85537_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"SF Wang","year":"2023","unstructured":"Wang, S. F., Tseng, L. M. & Lee, H. C. Role of mitochondrial alterations in human cancer progression and cancer immunity. J. Biomed. Sci. 30 (1), 61 (2023).","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"85537_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/1568009624666230912095526","volume":"24","author":"H Xiao","year":"2024","unstructured":"Xiao, H. et al. Mitochondrial calcium Uniporter (MCU) that modulates mitochondrial calcium uptake and facilitates endometrial Cancer Progression through Interaction with VDAC1. Curr. Cancer Drug Targets. 24 (3), 354\u2013367 (2024).","journal-title":"Curr. Cancer Drug Targets"},{"issue":"6","key":"85537_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41419-023-05891-0","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. FBXO7, a tumor suppressor in endometrial carcinoma, suppresses INF2-associated mitochondrial division. Cell. Death Dis. 14 (6), 368 (2023).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"85537_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman, J. V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15 (1), 10\u201317 (1983).","journal-title":"Gynecol. Oncol."},{"issue":"7447","key":"85537_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma. Nature 497 (7447), 67\u201373 (2013).","journal-title":"Nature"},{"issue":"43","key":"85537_CR16","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102 (43), 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"85537_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 16 (4), 385\u2013395 (1997).","journal-title":"Stat. Med."},{"key":"85537_CR18","doi-asserted-by":"publisher","first-page":"1434450","DOI":"10.3389\/fimmu.2024.1434450","volume":"15","author":"F Zhao","year":"2024","unstructured":"Zhao, F. et al. Elucidating the role of tumor-associated ALOX5\u2009+\u2009mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. Front. Immunol. 15, 1434450 (2024).","journal-title":"Front. Immunol."},{"key":"85537_CR19","doi-asserted-by":"publisher","first-page":"1438198","DOI":"10.3389\/fimmu.2024.1438198","volume":"15","author":"W Shao","year":"2024","unstructured":"Shao, W. et al. Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer. Front. Immunol. 15, 1438198 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"85537_CR20","doi-asserted-by":"publisher","first-page":"18813","DOI":"10.1038\/s41598-022-22879-6","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao, J. et al. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis. Sci. Rep. 12 (1), 18813 (2022).","journal-title":"Sci. Rep."},{"key":"85537_CR21","doi-asserted-by":"publisher","first-page":"1458638","DOI":"10.3389\/fimmu.2024.1458638","volume":"15","author":"X Li","year":"2024","unstructured":"Li, X. et al. Unveiling the cellular landscape: insights from single-cell RNA sequencing in multiple myeloma. Front. Immunol. 15, 1458638 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"85537_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"85537_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"85537_CR24","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"85537_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12672-024-01286-5","volume":"15","author":"L Sun","year":"2024","unstructured":"Sun, L. et al. Single-cell RNA sequencing explored potential therapeutic targets by revealing the tumor microenvironment of neuroblastoma and its expression in cell death. Discov Oncol. 15 (1), 409 (2024).","journal-title":"Discov Oncol."},{"issue":"7269","key":"85537_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462 (7269), 108\u2013112 (2009).","journal-title":"Nature"},{"key":"85537_CR27","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"issue":"10","key":"85537_CR28","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24 (10), 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"issue":"1","key":"85537_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell. Rep. 18 (1), 248\u2013262 (2017).","journal-title":"Cell. Rep."},{"issue":"Database issue","key":"85537_CR30","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41 (Database issue), D955\u2013D961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"85537_CR31","doi-asserted-by":"publisher","first-page":"1461489","DOI":"10.3389\/fimmu.2024.1461489","volume":"15","author":"Y Fang","year":"2024","unstructured":"Fang, Y. et al. Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models. Front. Immunol. 15, 1461489 (2024).","journal-title":"Front. Immunol."},{"key":"85537_CR32","doi-asserted-by":"publisher","first-page":"1070593","DOI":"10.3389\/fimmu.2022.1070593","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi, Y. et al. Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma. Front. Immunol. 13, 1070593 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"85537_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12957-022-02667-2","volume":"20","author":"Y Fang","year":"2022","unstructured":"Fang, Y. et al. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates. World J. Surg. Oncol. 20 (1), 211 (2022).","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"85537_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41419-023-05682-7","volume":"14","author":"SP Li","year":"2023","unstructured":"Li, S. P., Ou, L., Zhang, Y., Shen, F. R. & Chen, Y. G. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth. Cell. Death Dis. 14 (2), 152 (2023).","journal-title":"Cell. Death Dis."},{"issue":"11","key":"85537_CR35","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3724\/abbs.2022121","volume":"54","author":"HJ Hong","year":"2022","unstructured":"Hong, H. J. et al. ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer. Acta Biochim. Biophys. Sin (Shanghai). 54 (11), 1671\u20131683 (2022).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"issue":"3","key":"85537_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7150\/ijbs.23756","volume":"14","author":"G Li","year":"2018","unstructured":"Li, G. et al. Frizzled7 promotes epithelial-to-mesenchymal transition and Stemness Via activating Canonical Wnt\/\u03b2-catenin pathway in gastric Cancer. Int. J. Biol. Sci. 14 (3), 280\u2013293 (2018).","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"85537_CR37","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cellsig.2011.12.009","volume":"24","author":"TD King","year":"2012","unstructured":"King, T. D., Zhang, W., Suto, M. J. & Li, Y. Frizzled7 as an emerging target for cancer therapy. Cell. Signal. 24 (4), 846\u2013851 (2012).","journal-title":"Cell. Signal."},{"issue":"3","key":"85537_CR38","first-page":"992","volume":"13","author":"PP Ding","year":"2023","unstructured":"Ding, P. P. et al. PTPMT1 regulates mitochondrial death through the SLC25A6-NDUFS2 axis in pancreatic cancer cells. Am. J. Cancer Res. 13 (3), 992\u20131003 (2023).","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"85537_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1620\/tjem.250.263","volume":"250","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Membrane location of syntaxin-binding protein 1 is correlated with poor prognosis of Lung Adenocarcinoma. Tohoku J. Exp. Med. 250 (4), 263\u2013270 (2020).","journal-title":"Tohoku J. Exp. Med."},{"issue":"5","key":"85537_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/onc.2011.259","volume":"31","author":"SM Farabaugh","year":"2012","unstructured":"Farabaugh, S. M., Micalizzi, D. S., Jedlicka, P., Zhao, R. & Ford, H. L. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-\u03b2 signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 31 (5), 552\u2013562 (2012).","journal-title":"Oncogene"},{"issue":"67","key":"85537_CR41","doi-asserted-by":"publisher","first-page":"110837","DOI":"10.18632\/oncotarget.22860","volume":"8","author":"Z Li","year":"2017","unstructured":"Li, Z., Qiu, R., Qiu, X. & Tian, T. EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN. Oncotarget 8 (67), 110837\u2013110848 (2017).","journal-title":"Oncotarget"},{"issue":"1","key":"85537_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11060-018-03029-3","volume":"141","author":"CS Rahane","year":"2019","unstructured":"Rahane, C. S., Kutzner, A. & Heese, K. A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature. J. Neurooncol. 141 (1), 57\u201370 (2019).","journal-title":"J. Neurooncol"},{"key":"85537_CR43","unstructured":"Chatonnet, F. et al. The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation."},{"key":"85537_CR44","doi-asserted-by":"publisher","first-page":"689902","DOI":"10.3389\/fgene.2021.689902","volume":"12","author":"C Yu","year":"2021","unstructured":"Yu, C. et al. The dispensable roles of X-Linked Ubl4a and its autosomal counterpart Ubl4b in spermatogenesis represent a New Evolutionary type of X-Derived Retrogenes. Front. Genet. 12, 689902 (2021).","journal-title":"Front. Genet."},{"issue":"7","key":"85537_CR45","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ejhg.2014.214","volume":"23","author":"M Ol\u00e1hov\u00e1","year":"2015","unstructured":"Ol\u00e1hov\u00e1, M. et al. A truncating PET100 variant causing fatal infantile lactic acidosis and isolated cytochrome c oxidase deficiency. Eur. J. Hum. Genet. 23 (7), 935\u2013939 (2015).","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"85537_CR46","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang, R. & Zhou, P. K. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal. Transduct. Target. Ther. 6 (1), 254 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"85537_CR47","doi-asserted-by":"publisher","first-page":"e109823","DOI":"10.15252\/embj.2021109823","volume":"41","author":"JR Kovalski","year":"2022","unstructured":"Kovalski, J. R., Kuzuoglu-Ozturk, D. & Ruggero, D. Protein synthesis control in cancer: selectivity and therapeutic targeting. EMBO J. 41 (8), e109823 (2022).","journal-title":"EMBO J."},{"issue":"2","key":"85537_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3892\/or.2014.3651","volume":"33","author":"J Wang","year":"2015","unstructured":"Wang, J., Sun, X., Zhang, H., Wang, Y. & Li, Y. MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer. Oncol. Rep. 33 (2), 799\u2013809 (2015).","journal-title":"Oncol. Rep."},{"issue":"12","key":"85537_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41423-018-0163-3","volume":"15","author":"SM Poznanski","year":"2018","unstructured":"Poznanski, S. M. & Ashkar, A. A. Shining light on the significance of NK cell CD56 brightness. Cell. Mol. Immunol. 15 (12), 1071\u20131073 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"85537_CR50","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fimmu.2013.00438","volume":"4","author":"AM Dudek","year":"2013","unstructured":"Dudek, A. M., Martin, S., Garg, A. D., Agostinis, P. & Immature Semi-mature, and fully mature dendritic cells: toward a DC-Cancer cells interface that augments anticancer immunity. Front. Immunol. 4, 438 (2013).","journal-title":"Front. Immunol."},{"issue":"1","key":"85537_CR51","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s41467-018-04999-8","volume":"9","author":"W Xiang","year":"2018","unstructured":"Xiang, W. et al. Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression. Nat. Commun. 9 (1), 2574 (2018).","journal-title":"Nat. Commun."},{"issue":"2","key":"85537_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T., Qian, B. Z. & Pollard, J. W. Immune cell promotion of metastasis. Nat. Rev. Immunol. 15 (2), 73\u201386 (2015).","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"85537_CR53","first-page":"149","volume":"13","author":"H Wang","year":"2010","unstructured":"Wang, H. & Wang, Q. Zhongguo Fei Ai Za Zhi ;13(2):149\u2013153. (2010).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"3","key":"85537_CR54","doi-asserted-by":"publisher","first-page":"bbaa176","DOI":"10.1093\/bib\/bbaa176","volume":"22","author":"FF Hu","year":"2021","unstructured":"Hu, F. F., Liu, C. J., Liu, L. L., Zhang, Q. & Guo, A. Y. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Brief. Bioinform. 22 (3), bbaa176 (2021).","journal-title":"Brief. Bioinform."},{"issue":"22","key":"85537_CR55","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1200\/JCO.2017.72.5952","volume":"35","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. Safety and Antitumor Activity of Pembrolizumab in Advanced programmed death ligand 1-Positive endometrial Cancer: results from the KEYNOTE-028 study. J. Clin. Oncol. 35 (22), 2535\u20132541 (2017).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"85537_CR56","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam, A. & Prasad, V. Estimation of the percentage of US patients with Cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw. Open. 2 (5), e192535 (2019).","journal-title":"JAMA Netw. Open."},{"issue":"6","key":"85537_CR57","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s43018-022-00382-1","volume":"3","author":"V Anagnostou","year":"2022","unstructured":"Anagnostou, V., Bardelli, A., Chan, T. A. & Turajlic, S. The status of tumor mutational burden and immunotherapy. Nat. Cancer. 3 (6), 652\u2013656 (2022).","journal-title":"Nat. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85537-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:03:26Z","timestamp":1736449406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85537-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85537"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85537-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for this study was granted by the Ethics Review Committee of the Cancer Hospital of Shantou University Medical College.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1404"}}